BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10917532)

  • 21. The C. elegans model in toxicity testing.
    Hunt PR
    J Appl Toxicol; 2017 Jan; 37(1):50-59. PubMed ID: 27443595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications of CRISPR-Cas systems in neuroscience.
    Heidenreich M; Zhang F
    Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases.
    Chen X; Barclay JW; Burgoyne RD; Morgan A
    Chem Cent J; 2015; 9():65. PubMed ID: 26617668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An expanded Notch-Delta model exhibiting long-range patterning and incorporating MicroRNA regulation.
    Chen JS; Gumbayan AM; Zeller RW; Mahaffy JM
    PLoS Comput Biol; 2014 Jun; 10(6):e1003655. PubMed ID: 24945987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C. elegans in high-throughput drug discovery.
    O'Reilly LP; Luke CJ; Perlmutter DH; Silverman GA; Pak SC
    Adv Drug Deliv Rev; 2014 Apr; 69-70():247-53. PubMed ID: 24333896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using C. elegans to decipher the cellular and molecular mechanisms underlying neurodevelopmental disorders.
    Bessa C; Maciel P; Rodrigues AJ
    Mol Neurobiol; 2013 Dec; 48(3):465-89. PubMed ID: 23494747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Notch signaling inhibits axon regeneration.
    El Bejjani R; Hammarlund M
    Neuron; 2012 Jan; 73(2):268-78. PubMed ID: 22284182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.
    Calahorro F; Ruiz-Rubio M
    Invert Neurosci; 2011 Dec; 11(2):73-83. PubMed ID: 22068627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.
    Pandey UB; Nichols CD
    Pharmacol Rev; 2011 Jun; 63(2):411-36. PubMed ID: 21415126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases.
    Martinez-Finley EJ; Avila DS; Chakraborty S; Aschner M
    Metallomics; 2011 Mar; 3(3):271-9. PubMed ID: 21210060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.
    Ewald CY; Li C
    Brain Struct Funct; 2010 Mar; 214(2-3):263-83. PubMed ID: 20012092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inclusion body myositis: a view from the Caenorhabditis elegans muscle.
    Rebolledo DL; Minniti AN; Grez PM; Fadic R; Kohn R; Inestrosa NC
    Mol Neurobiol; 2008 Oct; 38(2):178-98. PubMed ID: 18773311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal morphogenesis is regulated by the interplay between cyclin-dependent kinase 5 and the ubiquitin ligase mind bomb 1.
    Choe EA; Liao L; Zhou JY; Cheng D; Duong DM; Jin P; Tsai LH; Peng J
    J Neurosci; 2007 Aug; 27(35):9503-12. PubMed ID: 17728463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of presenilins in the apoptosis of thymocytes and homeostasis of CD8+ T cells.
    Maraver A; Tadokoro CE; Badura ML; Shen J; Serrano M; Lafaille JJ
    Blood; 2007 Nov; 110(9):3218-25. PubMed ID: 17626841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.
    Evin G; Sernee MF; Masters CL
    CNS Drugs; 2006; 20(5):351-72. PubMed ID: 16696577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The GxGD motif of presenilin contributes to catalytic function and substrate identification of gamma-secretase.
    Yamasaki A; Eimer S; Okochi M; Smialowska A; Kaether C; Baumeister R; Haass C; Steiner H
    J Neurosci; 2006 Apr; 26(14):3821-8. PubMed ID: 16597736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notch signaling in Drosophila long-term memory formation.
    Ge X; Hannan F; Xie Z; Feng C; Tully T; Zhou H; Xie Z; Zhong Y
    Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10172-6. PubMed ID: 15220476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding sites of gamma-secretase inhibitors in rodent brain: distribution, postnatal development, and effect of deafferentation.
    Yan XX; Li T; Rominger CM; Prakash SR; Wong PC; Olson RE; Zaczek R; Li YW
    J Neurosci; 2004 Mar; 24(12):2942-52. PubMed ID: 15044533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch is required for long-term memory in Drosophila.
    Presente A; Boyles RS; Serway CN; de Belle JS; Andres AJ
    Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1764-8. PubMed ID: 14752200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation.
    Pigino G; Pelsman A; Mori H; Busciglio J
    J Neurosci; 2001 Feb; 21(3):834-42. PubMed ID: 11157069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.